QT Imaging Holdings, Inc. (简称QT Imaging) 近日宣布，其乳腺声学CT扫描仪的增强配置已获得美国食品药品监督管理局（FDA）的上市许可。
这一新配置专门针对后部乳腺组织的成像覆盖范围进行了优化升级，有望显著提升对乳腺后区域病变的检测能力。
FDA的批准意味着该增强型扫描仪可在美国市场正式投入临床使用，为乳腺疾病的早期诊断提供更全面的影像学支持。
QT Imaging Holdings, Inc. (简称QT Imaging) 近日宣布，其乳腺声学CT扫描仪的增强配置已获得美国食品药品监督管理局（FDA）的上市许可。
这一新配置专门针对后部乳腺组织的成像覆盖范围进行了优化升级，有望显著提升对乳腺后区域病变的检测能力。
FDA的批准意味着该增强型扫描仪可在美国市场正式投入临床使用，为乳腺疾病的早期诊断提供更全面的影像学支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.